{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:27:48Z","timestamp":1792783668055,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Contrat de Soutien \u00e0 la Recherche","award":["S-RD14004"],"award-info":[{"award-number":["S-RD14004"]}]},{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.biologicals.2018.03.004","type":"journal-article","created":{"date-parts":[[2018,3,24]],"date-time":"2018-03-24T01:34:49Z","timestamp":1521855289000},"page":"19-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Innovative in cellulo method as an alternative to in vivo neurovirulence test for the characterization and quality control of human live Yellow Fever virus vaccines: A pilot study"],"prefix":"10.1016","volume":"53","author":[{"given":"Anaelle","family":"da Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Prehaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Khou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Pardigon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aure","family":"Saulnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nolwenn","family":"Nougarede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Lafon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2018.03.004_bib1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.virol.2015.03.032","article-title":"Live attenuated vaccines: historical successes and current challenges","volume":"479\u2013480","author":"Minor","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.biologicals.2018.03.004_bib2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.20506\/rst.26.2.1748","article-title":"Regulatory requirements for vaccine authorisation","volume":"26","author":"Jones","year":"2007","journal-title":"Rev Sci Tech"},{"issue":"Suppl 1","key":"10.1016\/j.biologicals.2018.03.004_bib3","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1542\/peds.2010-1722E","article-title":"Food and Drug Administration regulation and evaluation of vaccines","volume":"127","author":"Marshall","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.biologicals.2018.03.004_bib4","series-title":"Recommendations to assure the quality, safety and efficacy of live attenuated yellow fever vaccines","first-page":"978","author":"WHO","year":"2012"},{"key":"10.1016\/j.biologicals.2018.03.004_bib5","series-title":"Yellow fever vaccine","author":"0537 M","year":"2013"},{"key":"10.1016\/j.biologicals.2018.03.004_bib6","series-title":"Biomaterials science and tissue engineering: principles and methods","author":"Basu","year":"2017"},{"key":"10.1016\/j.biologicals.2018.03.004_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neuropharm.2014.09.020","article-title":"Synaptic receptor dynamics: from theoretical concepts to deep quantification and chemistry in cellulo","volume":"88","author":"Salvatico","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biologicals.2018.03.004_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1749-6632.2011.06335.x","article-title":"Animal welfare and the 3Rs in European biomedical research","volume":"1245","author":"Wells","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.biologicals.2018.03.004_bib9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.14573\/altex.2013.3.378","article-title":"Alternative methods: 3Rs, research and regulatory aspects","volume":"30","author":"Caloni","year":"2013","journal-title":"ALTEX"},{"key":"10.1016\/j.biologicals.2018.03.004_bib10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.14573\/altex.2011.4.341","article-title":"A framework program for the teaching of alternative methods (replacement, reduction, refinement) to animal experimentation","volume":"28","author":"Daneshian","year":"2011","journal-title":"ALTEX"},{"key":"10.1016\/j.biologicals.2018.03.004_bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/15265160903323095","article-title":"Information on the 3Rs in animal research publications is crucial","volume":"9","author":"Whittall","year":"2009","journal-title":"Am J Bioeth"},{"key":"10.1016\/j.biologicals.2018.03.004_bib12","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/ilar\/ilw033","article-title":"Animal research, the 3Rs, and the \u201cinternet of things\u201d: opportunities and oversight in international pharmaceutical development","volume":"57","author":"Niemi","year":"2016","journal-title":"ILAR J"},{"key":"10.1016\/j.biologicals.2018.03.004_bib13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jinf.2014.05.010","article-title":"Flaviviruses are neurotropic, but how do they invade the CNS?","volume":"69","author":"Neal","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.biologicals.2018.03.004_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.coviro.2014.12.009","article-title":"Viral diseases of the central nervous system","volume":"11","author":"Swanson","year":"2015","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.biologicals.2018.03.004_bib15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature04388","article-title":"Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population","volume":"439","author":"Vignuzzi","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.biologicals.2018.03.004_bib16","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.neuint.2010.02.016","article-title":"Neurons under viral attack: victims or warriors?","volume":"56","author":"Chakraborty","year":"2010","journal-title":"Neurochem Int"},{"key":"10.1016\/j.biologicals.2018.03.004_bib17","doi-asserted-by":"crossref","first-page":"12893","DOI":"10.1128\/JVI.79.20.12893-12904.2005","article-title":"Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon","volume":"79","author":"Prehaud","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.biologicals.2018.03.004_bib18","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.tins.2015.08.003","article-title":"The molecular constituents of the blood-brain barrier","volume":"38","author":"Chow","year":"2015","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.biologicals.2018.03.004_bib19","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nm.3407","article-title":"Development, maintenance and disruption of the blood-brain barrier","volume":"19","author":"Obermeier","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.biologicals.2018.03.004_bib20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.tim.2012.03.009","article-title":"Viral disruption of the blood-brain barrier","volume":"20","author":"Spindler","year":"2012","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.biologicals.2018.03.004_bib21","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/mt.2009.71","article-title":"Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons","volume":"17","author":"Duque","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.biologicals.2018.03.004_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0168-1702(00)00168-4","article-title":"The French neurotropic vaccine strain of yellow fever virus accumulates mutations slowly during passage in cell culture","volume":"69","author":"Holbrook","year":"2000","journal-title":"Virus Res"},{"key":"10.1016\/j.biologicals.2018.03.004_bib23","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1001\/jama.300.8.960","article-title":"Yellow fever: 100 years of discovery","volume":"300","author":"Staples","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.biologicals.2018.03.004_bib24","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1016\/j.vaccine.2017.03.032","article-title":"Yellow fever live attenuated vaccine: a very successful live attenuated vaccine but still we have problems controlling the disease","volume":"35","author":"Barrett","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2018.03.004_bib25","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1084\/jem.65.6.787","article-title":"The use of yellow fever virus modified by in vitro cultivation for human immunization","volume":"65","author":"Theiler","year":"1937","journal-title":"J Exp Med"},{"key":"10.1016\/j.biologicals.2018.03.004_bib26","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1096\/fj.04-3458fje","article-title":"Blood-brain barrier-specific properties of a human adult brain endothelial cell line","volume":"19","author":"Weksler","year":"2005","journal-title":"Faseb J"},{"key":"10.1016\/j.biologicals.2018.03.004_bib27","doi-asserted-by":"crossref","first-page":"15226","DOI":"10.1128\/JVI.79.24.15226-15237.2005","article-title":"Modulation of HLA-G expression in human neural cells after neurotropic viral infections","volume":"79","author":"Lafon","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.biologicals.2018.03.004_bib28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0165-3806(03)00065-8","article-title":"Turning teratocarcinoma cells into neurons: rapid differentiation of NT-2 cells in floating spheres","volume":"142","author":"Paquet-Durand","year":"2003","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1016\/j.biologicals.2018.03.004_bib29","doi-asserted-by":"crossref","first-page":"946","DOI":"10.2144\/99265rr04","article-title":"Production of human CNS neurons from embryonal carcinoma cells using a cell aggregation method","volume":"26","author":"Cheung","year":"1999","journal-title":"Biotechniques"},{"key":"10.1016\/j.biologicals.2018.03.004_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0304-3940(94)11792-H","article-title":"Establishment of human microglial cell lines after transfection of primary cultures of embryonic microglial cells with the SV40 large T antigen","volume":"195","author":"Janabi","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biologicals.2018.03.004_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s13365-016-0499-3","article-title":"Immortalization of primary microglia: a new platform to study HIV regulation in the central nervous system","volume":"23","author":"Garcia-Mesa","year":"2017","journal-title":"J Neurovirol"},{"key":"10.1016\/j.biologicals.2018.03.004_bib32","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jcp.1041320115","article-title":"Molecular sieving characteristics of the cultured endothelial monolayer","volume":"132","author":"Siflinger-Birnboim","year":"1987","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.biologicals.2018.03.004_bib33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.brainres.2012.06.046","article-title":"Low extracellular Ca2+ conditions induce an increase in brain endothelial permeability that involves intercellular Ca2+ waves","volume":"1487","author":"De Bock","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.biologicals.2018.03.004_bib34","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.tiv.2015.05.016","article-title":"Evaluation of drug-induced neurotoxicity based on metabolomics, proteomics and electrical activity measurements in complementary CNS in vitro models","volume":"30","author":"Schultz","year":"2015","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.biologicals.2018.03.004_bib35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12985-016-0590-7","article-title":"Flavivirus NS1: a multifaceted enigmatic viral protein","volume":"13","author":"Rastogi","year":"2016","journal-title":"Virol J"},{"key":"10.1016\/j.biologicals.2018.03.004_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrmicro1067","article-title":"A structural perspective of the flavivirus life cycle","volume":"3","author":"Mukhopadhyay","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.biologicals.2018.03.004_bib37","doi-asserted-by":"crossref","first-page":"14883","DOI":"10.1038\/s41598-017-13980-2","article-title":"Zika virus infects intermediate progenitor cells and post-mitotic committed neurons in human fetal brain tissues","volume":"7","author":"Lin","year":"2017","journal-title":"Sci Rep"},{"issue":"Pt 4","key":"10.1016\/j.biologicals.2018.03.004_bib38","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1099\/0022-1317-67-4-631","article-title":"Comparison of neurovirulence of different strains of yellow fever virus in mice","volume":"67","author":"Barrett","year":"1986","journal-title":"J Gen Virol"},{"key":"10.1016\/j.biologicals.2018.03.004_bib39","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.medmal.2008.11.013","article-title":"Yellow fever vaccination: update on rare and severe adverse effects","volume":"39","author":"Receveur","year":"2009","journal-title":"Med Maladies Infect"},{"key":"10.1016\/j.biologicals.2018.03.004_bib40","first-page":"671","article-title":"The effect of selective phosphatase inhibitors Salubrinal on autophagy and apoptosis in the lung tissue of rats with acute paraquat poisoning","volume":"26","author":"Li","year":"2014","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"10.1016\/j.biologicals.2018.03.004_bib41","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12031-011-9575-6","article-title":"Role of autophagy in early brain injury after experimental subarachnoid hemorrhage","volume":"46","author":"Wang","year":"2012","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.biologicals.2018.03.004_bib42","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1084\/jem.20082292","article-title":"Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses","volume":"205","author":"Gaucher","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.biologicals.2018.03.004_bib43","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.biologicals.2018.03.004_bib44","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1586\/14760584.2013.836320","article-title":"Safety profile of the yellow fever vaccine Stamaril(R): a 17-year review","volume":"12","author":"Cottin","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.biologicals.2018.03.004_bib45","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/14760584.4.4.553","article-title":"Yellow fever vaccine","volume":"4","author":"Monath","year":"2005","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.biologicals.2018.03.004_bib46","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/infdis\/jit546","article-title":"Comparison of the live attenuated yellow fever vaccine 17D-204 strain to its virulent parental strain Asibi by deep sequencing","volume":"209","author":"Beck","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.biologicals.2018.03.004_bib47","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.biologicals.2011.04.001","article-title":"Neurovirulence tests of three 17D yellow fever vaccine strains","volume":"39","author":"Minor","year":"2011","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2018.03.004_bib48","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1084\/jem.77.6.487","article-title":"Immunity to yellow fever encephalitis of monkeys and mice immunized by neural and extraneural routes","volume":"77","author":"Fox","year":"1943","journal-title":"J Exp Med"},{"key":"10.1016\/j.biologicals.2018.03.004_bib49","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0092-1157(87)80003-3","article-title":"The monkey safety test for neurovirulence of yellow fever vaccines: the utility of quantitative clinical evaluation and histological examination","volume":"15","author":"Levenbook","year":"1987","journal-title":"J Biol Stand"},{"key":"10.1016\/j.biologicals.2018.03.004_bib50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/026119291704500309","article-title":"Pain in laboratory animals: a possible confounding factor?","volume":"45","author":"Sneddon","year":"2017","journal-title":"Altern Lab Anim"},{"key":"10.1016\/j.biologicals.2018.03.004_bib51","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1242\/jeb.147058","article-title":"Considering aspects of the 3Rs principles within experimental animal biology","volume":"220","author":"Sneddon","year":"2017","journal-title":"J Exp Biol"},{"key":"10.1016\/j.biologicals.2018.03.004_bib52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/2045-8118-10-16","article-title":"The hCMEC\/D3 cell line as a model of the human blood brain barrier","volume":"10","author":"Weksler","year":"2013","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.biologicals.2018.03.004_bib53","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4269\/ajtmh.2007.77.919","article-title":"Yellow fever 17-D vaccine is neurotropic and produces encephalitis in immunosuppressed hamsters","volume":"77","author":"Mateo","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.biologicals.2018.03.004_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.04.001","article-title":"Brain development in rodents and humans: identifying benchmarks of maturation and vulnerability to injury across species","volume":"106\u2013107","author":"Semple","year":"2013","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.biologicals.2018.03.004_bib55","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.biologicals.2005.03.009","article-title":"Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys","volume":"33","author":"Monath","year":"2005","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2018.03.004_bib56","first-page":"127","article-title":"Neurovirulence","volume":"101","author":"Wood","year":"1999","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.biologicals.2018.03.004_bib57","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4161\/hv.4.2.5070","article-title":"Collaborative vaccine development: partnering pays","volume":"4","author":"Ramachandra","year":"2008","journal-title":"Hum Vaccine"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105618300630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105618300630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T01:39:48Z","timestamp":1589852388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105618300630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":57,"alternative-id":["S1045105618300630"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2018.03.004","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innovative in cellulo method as an alternative to in vivo neurovirulence test for the characterization and quality control of human live Yellow Fever virus vaccines: A pilot study","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2018.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}